# Sources — Florence Griffith Joyner

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 4, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Olympedia. “Florence Griffith Joyner.” Supports her full name as Delorez Florence Griffith Joyner; birth on December 21, 1959, in Los Angeles; death on September 21, 1998, in Mission Viejo, California; the 1984 Olympic silver medal in the 200 meters; the 1988 world record of 10.49 seconds for 100 meters at the U.S. Olympic Trials; three gold medals and a silver at Seoul, with 21.34 seconds in the 200-meter final; and published height. https://www.olympedia.org/athletes/77849
2. Encyclopedia.com. “Griffith Joyner, Florence” (biographical entries). Supports her birth as the seventh of eleven children, her move at four to a public housing project in Watts, California State University, Northridge, UCLA (1983), the 1984 silver medal, retirement from competition in 1989, co-chair of the President’s Council on Physical Fitness (1993), the U.S. Track and Field Hall of Fame (1995), and the 1996 seizure on an airplane with a day of observation in hospital. The entries give her given names as both “Florence Delorez” and “Delorez Florence.” https://encyclopedia.com/people/sports-and-games/sports-biographies/florence-griffith-joyner
3. The Associated Press. “Flo Jo reportedly doing fine after having seizure on plane,” *The Spokesman-Review*, April 6, 1996. Published during her life: supports that she was released from hospital a day after a seizure on an airplane en route to St. Louis and that the family asked that no other details be released. https://www.spokesman.com/stories/1996/apr/06/flo-jo-reportedly-doing-fine-after-having-seizure/
4. Rebelo Anderson K. “The uneasy death of Florence Griffith Joyner,” *Salon*, November 30, 1998. A report based on the coroner’s investigation records: supports that she had a grand mal seizure in 1990 and had been treated for seizures in 1990, 1993 and 1994, and the amended cause of death (positional asphyxia; epileptiform seizure; cavernous angioma, left orbital frontal cerebrum). Used for nothing else. https://salon.com/1998/11/30/newsa_26
5. *The Irish Times*. “No direct drug link to FloJo death,” October 23, 1998. Supports the coroner’s statement that she “died as a result of positional asphyxia, secondary to an epileptic seizure” brought on by a congenital defect in her brain, and her world records. https://www.irishtimes.com/sport/no-direct-drug-link-to-flojo-death-1.206659
6. The Associated Press. “Joyner autopsy reveals seizure,” CBS News, October 22, 1998. Supports that she suffocated during an epileptic seizure in her sleep and that the coroner’s investigator described a cavernous angioma on the front left part of her brain. https://www.cbsnews.com/news/joyner-autopsy-reveals-seizure/
7. World Athletics (IAAF). “Autopsy proves Flo-Jo suffered an epileptic seizure,” October 23, 1998. Supports death by suffocation in her sleep after an epileptic seizure, at home in Mission Viejo, and a congenital cavernous angioma. https://worldathletics.org/news/news/autopsy-proves-flo-jo-suffered-an-epileptic-s
8. *Deseret News*. “Seizure, suffocation caused Flojo’s death,” October 23, 1998. Supports that the angioma was a congenital abnormality she might have been born with. https://www.deseret.com/1998/10/23/19408230/seizure-suffocation-caused-flojo-s-death/
9. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. Krumholz A, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults. American Academy of Neurology and American Epilepsy Society, *Neurology* 2015;84:1705-1713 (PMID 25901057): EEG and brain imaging after a first seizure; recurrence risk highest in the first two years and raised by an epileptiform EEG and a brain lesion; immediate treatment lowers early recurrence. https://pubmed.ncbi.nlm.nih.gov/25901057/
2. Fisher RS, et al. ILAE official report: a practical clinical definition of epilepsy. *Epilepsia* 2014;55:475-482 (PMID 24730690): epilepsy after one unprovoked seizure when the probability of another is at least 60%. https://pubmed.ncbi.nlm.nih.gov/24730690/
3. Akers A, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations (Angioma Alliance). *Neurosurgery* 2017;80:665-680 (PMID 28387823): susceptibility-weighted MRI; genetic testing for multiple lesions or a family history; surgical resection considered for epilepsy from an accessible lesion, with early surgery favored. https://pubmed.ncbi.nlm.nih.gov/28387823/
4. Harden C, et al. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors. AAN and AES, *Neurology* 2017;88:1674-1680 (PMID 28438841): clinicians should inform patients about SUDEP; generalized tonic-clonic seizures are the major risk factor; nocturnal supervision may lower risk. https://pubmed.ncbi.nlm.nih.gov/28438841/
5. Pack AM, et al. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication. AAN, AES and SMFM, *Neurology* 2024 (PMID 38748979): lamotrigine and levetiracetam among the lowest risks; valproate avoided; folic acid at least 0.4 mg daily. https://pubmed.ncbi.nlm.nih.gov/38748979/
6. Beniczky S, et al. Automated seizure detection using wearable devices: ILAE and IFCN clinical practice guideline. *Epilepsia* 2021;62:632-646 (PMID 33666944). https://pubmed.ncbi.nlm.nih.gov/33666944/
7. Office of the Governor of California. Veto message for Senate Bill 357, September 28, 2024: physician reporting of disorders characterized by lapses of consciousness to local health officers, and from them to the DMV, remains mandatory. https://www.gov.ca.gov/wp-content/uploads/2024/09/SB-357-Veto-Message.pdf
8. U.S. Preventive Services Task Force: A and B recommendations, depression (2023), cervical cancer (2018), breast cancer (2024), and intimate partner violence (2025); CDC Adult Immunization Schedule; Medicare Preventive Services reference (Aether Forge, 2026). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations

The CMID has no epilepsy monograph, so the focused visits follow the specialty guidelines above.

## Editorial resolutions

- **Recent-death rule.** Griffith Joyner died in 1998, so the rule applies. The case uses what was reported during her life (the Associated Press report of the 1996 seizure), the coroner’s findings as reported by news organizations and World Athletics, and reference works for her life and career. The earlier treated seizures come from the coroner’s investigation records as reported by *Salon* after her death; they are graded probable (CLM-0006) and are used only as history. On November 5, 2026 the project lead accepted this source under the recent-death rule because it is documented and annotated here. No sick visit is added. Her death is recorded once (CLM-0007), in plain words. No claim concerns mental health or substance use; the modern mood screens are synthetic and below the threshold for a safety assessment.
- **What is left out.** The family asked in 1996 that no details of that seizure be released, and the modern episode respects that: it adds no account of the real seizure beyond what was published, and the description of the seizure in the modern notes (witnessed stiffening and jerking, confusion afterwards, no memory of it) is synthetic and generic. Details from the coroner’s scene and investigation notes and the statements of relatives are not used. Rumors about performance-enhancing drugs, which were never proven, are not part of the clinical record; the coroner’s toxicology showed only over-the-counter medicines in usual amounts, and an Associated Press report said the autopsy found no indication of drug use (CBS News).
- **Real people.** No relative is named, and no statement, decision or health fact is attributed to any relative. The household is described only as married with a young child, without names or roles; the nocturnal detection watch alerts “a contact she chose.” Officials quoted in the reports appear only as their sources. The family history is left empty.
- **Conflicts.** (1) Her given names appear as Delorez Florence (Olympedia) and Florence Delorez (Encyclopedia.com); CLM-0001 records both. (2) The coroner’s investigator was reported as saying cavernous angiomas are found in about 25 percent of the population (CBS News) and in 0.25 percent (World Athletics); the second matches the medical literature, and neither figure is used. (3) The *Irish Times* spells the chief forensic pathologist’s name differently from the other reports; the name is not used. (4) Her stay after the 1996 seizure is described as release the next day (Associated Press, 1996) and as a day under observation (Encyclopedia.com), which agree. (5) The *Los Angeles Times* and *New York Times* reports could not be fetched and are not cited; the *Los Angeles Times* is quoted only through *Salon*, and that quotation is not used.
- **Alias.** “Flo-Jo” appears in no other record and is used as an alias, with her full name. “Griffith” is part of her family name, not an alias; `identity.name_parts` gives the family name as “Griffith Joyner.”
- **Index age and dates.** The index visit on April 22, 2026 maps to April 22, 1996, when she was 36: about two and a half weeks after the seizure on a flight, the first seizure reported publicly in her life. The synthetic date of birth is December 21, 1989 (shift 30 years). The chronic-care visits on May 5, May 27, July 21 and October 20, 2026, the surgery on June 16, and the preventive visit on August 25, 2026 (age 36, so a periodic adult preventive visit) map to the same days of 1996, two years before her death. Past medical history includes the treated seizures of 1990 to 1994 and the April 1996 seizure, both before the index date.
- **Synthetic clinical picture.** The presenting problem is the seizure on the flight (R56.9), resolved at the consultation when the EEG and MRI give the diagnosis: focal epilepsy with structural cause from a left orbitofrontal cavernous malformation, the site the coroner reported. Because the record documents earlier treated seizures, the modern episode does not call this her first seizure; it is evaluated as a new seizure under the AAN/AES first seizure guideline because no earlier records are available, and the diagnosis of epilepsy rests on the ILAE 2014 single-seizure criterion with an epileptogenic lesion, supported by the history. The seizure type, EEG findings, MRI details (size, hemosiderin rim, developmental venous anomaly, single lesion), levetiracetam, folic acid, the lesionectomy and its pathology, and every value are synthetic. Levetiracetam was chosen over lamotrigine for an immediate effective dose without contraceptive interaction; valproate is named only as the drug to avoid. Early lesionectomy after one evaluated seizure is a judgment call supported by the Angioma Alliance guideline for an accessible epileptogenic lesion. California’s mandatory physician report is applied because she lived in California. Height 170 cm matches her published athletic height; weights are synthetic. Qualitative results (pregnancy test, EEG, MRI, pathology, cervical screening, HIV and hepatitis tests) appear only in procedure and note text.
- **Sleep and SUDEP.** The SUDEP counseling follows the AAN/AES guideline in general terms (tonic-clonic seizures as the main risk, adherence, regular sleep, nocturnal supervision or detection). It deliberately does not discuss sleeping position or bedding, so that no part of the modern episode reads as commentary on the circumstances of her death.
- **Preventive visit.** A periodic adult preventive visit at 36 (CPT 99395 with 99497 in plain text), ten weeks after surgery. Judgment calls: cervical cytology with HPV co-testing; once-in-adulthood HIV, hepatitis C and hepatitis B screening; intimate partner violence screening for a woman of reproductive age; folic acid continued; mammography from 40; no diabetes or lipid screening at 36 with a normal BMI and no risk factor; Tdap given. Advance care planning records only her general preferences and an unnamed agent.
- **Focused visits.** The four chronic-care follow-ups (two weeks with the diagnosis and consultation, three weeks on levetiracetam, five weeks after surgery, six and a half months after the seizure) are documented as focused visits on the AAN/AES first seizure guideline, the ILAE 2014 definition, the Angioma Alliance guideline, the AAN/AES SUDEP guideline, the AAN/AES/SMFM 2024 teratogenesis guideline and the ILAE/IFCN detection guideline. One deviation is recorded instead of an invented event: the SUDEP discussion the guideline calls for at diagnosis was not held at the consultation visit, because the visit was taken up by the diagnosis, the medication and the surgical question; it was held three weeks later, no seizure occurred in the interval, and SUDEP was added to the clinic’s new-diagnosis checklist. Synthetic findings introduced: mild irritability and tiredness on levetiracetam that settled without a change of drug, and complete resection on the postoperative MRI.
- **Consultation.** The epilepsy referral, written at intake before the EEG and MRI, and the consultation by Rahul Mehta-Sorensen, MD (a fictional consultant), on the day of the two-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: focal epilepsy with structural cause under ILAE 2014; levetiracetam with folic acid, contraception and pregnancy planning, and valproate avoided; neurosurgical evaluation, which led to complete lesionectomy; SUDEP counseling at the next visit, with a detection watch; and safety, flying, graded training and driving through the California DMV.
